ConocoPhillips (0QZA)
London Stock Exchange · UK · prices in USD · close of 27 Oct 2026
Key indicators
| Last close | USD 147.99 |
|---|---|
| 52-week range | 85.64 – 154.00 |
| Return, 1 month / 3 months | +16.3% / +26.7% |
| Return, 1 year / 3 years | +68.7% / +34.7% |
| Trend | Uptrend |
| RSI (14) | 68 |
| Volatility (1 year) | 30.1% |
| Worst drawdown (1 year) | -22.9% |
| Average daily value traded | 1.82M USD |
| Dividend yield | 0.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ConocoPhillips is an independent energy company focused on exploring for and producing crude oil and natural gas. It operates in several regions around the world, including the United States, Europe, Asia and Australia, and its customers are mainly refiners, utilities and other buyers of oil and gas. The company is based in Houston, Texas, and its business centres on finding, developing and extracting hydrocarbons from conventional and unconventional fields.
The shares are listed on the London Stock Exchange in UK under the code 0QZA, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ConocoPhillips (0QZA) trades on the London Stock Exchange in UK. It last closed at USD 147.99 on 27 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 490 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 68.7% and over the last three months it rose 26.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 87 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 22.7% | ||
| From 52-week high | -2.5% | ||
| Momentum | 87 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 26.7% | ||
| 6-month return | 22.0% | ||
| 12-month return, skipping the last month | 45.0% | ||
| Stability (higher is calmer) | 64 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.9% | ||
| Liquidity | 59 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.82M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 24 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.6% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.5% |
|---|---|
| 1 month | +16.3% |
| 3 months | +26.7% |
| 6 months | +22.0% |
| 1 year | +68.7% |
| 3 years | +34.7% |
| 5 years | +127.9% |
Signals
| 50-day / 200-day average | 135.18 / 120.57 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.25 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Nov 2025 | USD 0.8400 |
| 15 Aug 2025 | USD 0.7800 |
| 16 May 2025 | USD 0.7800 |
| 14 Feb 2025 | USD 0.7800 |
| 8 Nov 2024 | USD 0.7800 |
| 12 Aug 2024 | USD 0.5800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.